NUA SURGICAL

All of #Ireland are very proud of these amazing athletes. They are an inspiration to the young girls throughout the country.

Thank you HealthTech Ireland for showcasing our company and Innovation as previous winners of these prestigious awards. As our CEO Barry Mc Cann states below, we are dedicated to making a positive impact in our field and we can do this through our innovations and through advocacy. Winning these awards in 2023 helps fulfil our mission to shine a light on the significant gaps in women's health.

We are extremely proud of our Board Chair, Dr. Elizabeth Garner, who joins the phenomenal team at WHAM as a Strategic Advisor. Undoubtedly, great things will come from this collaboration! #womenshealth #healthequity

Katie Hobbins, Managing Editor of MD+DI, has recently named NUA SURGICAL as one of the #Femtech Companies to Watch in 2024! This list was produced following a recent video interview with Brittany Barreto, Ph.D. who also highlighted NUA as one of the top femtech companies innovating the space. We are in great company alongside Aspivix, Hyivy Health, MOLLI Surgical, Aavia, and ENDODIAG. The article also highlights the growing value of the FemTech sector: Valued at $50.97 billion in 2023, the global femtech market is projected to grow at a CAGR of 15.38% from 2024 to 2032 ($177.05 billion). Additionally, according to FemTech Analytics, venture capital (VC) investments in femtech companies have quadrupled since 2015, rising from $600 million to nearly $2.4 billion in 2021. Thank you to Katie, Brittany and all those who constantly shine a spotlight on the important work start-ups are doing in women's health.

We are excited to announce our new investment in NUA SURGICAL a women's health company developing innovative surgical solutions in obstetrics. Their SteriCISION C-section retractor is designed to improve the ergonomics and decrease the risk of surgical complications for #Csections, ultimately improving safety for women, and assuring the best outcomes for mothers and babies. Elizabeth Garner Barry McCann #womenshealth #reproductivehealth #maternalhealth #laboranddelivery #obgyn #obstetrics #gynecology

At the end of May, 51 Labs, MATTER’s women’s health accelerator, culminated with an in-person showcase in Chicago. The Accelerator focused on advancing the development of innovations addressing maternal mortality and morbidity in the United States and NUA SURGICAL were proud to be among the cohort.  The event opened with a keynote address by Elizabeth Cherot MD,MBA, president and CEO of March of Dimes who highlighted to importance of innovation if we are to see a change in outcomes. It was also a fantastic opportunity for us to showcase our innovation in front of key opinion leaders in the women's health industry. The accelerator enabled us to develop some strong relationships across the maternal health sector and we look forward to building on these in the months and years ahead. These include the partners of the accelerator; Health Care Service Corporation, Laerdal Million Lives Fund, BayCare Health System, Parkview Mirro Center for Research and Innovation, UChicago Medicine, Organon and Stryker. I also look forward to following the exciting journey of our fellow cohort companies: Armor Medical Inc, BAKS Medical, BioticsAI, Ciconia Medical, Elythea (YC S23), Expect Fitness, Malama Health, Partum Health, Vasowatch

In a world of fake news, it is important to take information from the right sources and when it comes to maternal and infant health, the March of Dimes is among the most credible. Maternal health needs to see change and unless we do something, the situation will get worse.

Only getting a chance now to recap on a great few days in San Francisco for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting. The meeting started last Friday and for me, the standout presentation was from ACOG Past President Dr Lisa Hollier. She updated the audience on startling new data from the CDC that maternal morbidity and mortality in the US continues to rise, and there was a clear call to action for Obstetricians to lead from the bedside and influence change. The data from the MMRC shows that 84% of Maternal Deaths in the US in 2020 were PREVENTABLE. By all accounts, this is unacceptable but on a positive note, there is a sense of urgency around fixing this, particularly with the wave of support and focus coming from a governmental level. It was great to catch up fellow #European innovator Ikram Guerd of Aspivix and see their progress on the US market. And also with our board chair, Elizabeth Garner, to discuss progress within our company. I left San Fran for Chicago on Monday for the #51Labs Showcase today alongside 9 other inspirational maternal health start ups. More on that in the coming days....

Our CEO Barry McCann is in Chicago today for the MATTER 51 Labs Maternal Health Showcase. This an in-person and virtual event, so if you would like to learn more about NUA SURGICAL and 9 other maternal health start-ups, please register via the link below. #maternalhealth #womenshealth BioInnovate Ireland ATU Innovation Hubs University of Galway Enterprise Ireland Enterprise Ireland USA

I will be attending the American College of Obstetricians and Gynecologists (ACOG)’s 2024 Annual Clinical & Scientific Meeting, being held in San Francisco, California, from May 17 to May 19, and look forward to catching up with many of my clinical and industry connections! If you are attending and would like to discuss NUA SURGICAL, our patented maternal health technology, potential collaborations or anything in between, please reach out to me directly. #Womenshealth, #maternity, Enterprise Ireland USA